The neuronal localization of glutamate and phencyclidine (PCP) receptors was evaluated in the cerebral cortex and hippocampal formation of rat CNS using quantitative autoradiography. Scatchard analysis of [3H]glutamate binding in the cortex (layers I and II and V and VI) showed no difference in the total number of binding sites (Bm~x) or apparent affinity (Kd) 1 week, 1 month and 2 months following unilateral ibotenate lesions to nucleus basalis of Meynert (nbM) compared to the non-lesioned side. Quisqualic acid displacement of [3H]glutamate in layers I and II, 1 week following nbM destruction, revealed both high-and low-affinity binding sites (representing the quisqualate (QA) and N-methyI-D-aspartate (NMDA) sites, respectively). Compared to the control side, there was no difference in binding parameters for either of the receptor sites. In similarly lesioned animals, the NMDA receptor was specifically labelled with [3H]glutamate and the associated PCP receptor labelled with [3H]N-(1-[2-thienyl]cyclohexyl)3,4-piperidine ([3H]TCP) in adjacent brain sections. For both receptors, there was no change in the total number of binding sites in the cortex following destruction of nbM. On the other hand, virtually all binding to NMDA and PCP receptors was eliminated following chemical destruction of intrinsic cortical neurons. These results suggest that the NMDA/PCP receptor complex does not exist on the terminals of cortical cholinergic afferents. One week after knife cuts of the glutamatergic entorhinal pathway to the hippocampai formation only an approximate 10% reduction of NMDA and PCP receptors was seen in the dentate gyrus. Conversely, selective destruction of the dentate granule cells using colchicine caused a near identical loss of NMDA and PCP receptors (84% vs 92% respectively). It is concluded from these experiments that glutamate and PCP receptors exist almost exclusively on neurons intrinsic to the hippocampal formation and that no more than 10% of NMDA and PCP receptors exist as autoreceptors on glutamatergic terminals.
INTRODUCTION
Glutamate is a major excitatory neurotransmitter in the mammalian central nervous system which activates at least 4 receptor subtypes 75. Due to the availability of selective antagonists for experimental analysis, the Nmethyl-o-aspartate (NMDA) receptor has been most thoroughly investigated. NMDA receptors occur in highest density in subregions of the hippocampal formation and in layers I and II of the cerebral cortex 19'45. Activation of this receptor seems to be necessary for the induction of long-term potentiation 24'46 and may be important in the development of seizures 1°A5'26 as well as neuronal destruction caused by hypoxiaJischemia 23'5s'69 and hypoglycemia 74 . NMDA receptors have also been shown to be decreased in the cerebral cortex 2° and hippocampal formation 21'54 of patients with dementia of the Alzheimer type (DAT).
The dissociative anesthetics (e.g. phencyclidine and ketamine) are a unique class of drugs which are thought to interact with the NMDA receptor. Electrophysiologically, these drugs have been shown to block the activation of the NMDA receptor in the spinal cord and cortex 13,33'65. The dissociative anesthetics also inhibit the induction of long-term potentiation 62 and NMDA-induced neuronal degeneration 5°. Drugs like PCP and ketamine appear to act as non-competitive inhibitors of the NMDA receptor 25'41 and probably exert their effects at an allosteric site on the receptor complex 35 . Support for this concept comes from binding studies demonstrating that the dissociative anesthetic binding sites possess a distribution identical to that of the NMDA receptor in the rat forebrain 4°. The NMDA receptor complex has also been solubilized from rat and pig brains 42 and expressed in Xenopus oocytes injected with either rat brain 3°,67 or mouse neuroblastoma-Chinese hamster brain hybrid 32 mRNA. In both instances the NMDA receptor complex displayed pharmacological and physiological properties similar to those seen in both membrane and tissue preparations. 
MATERIALS AND METHODS

Surgery
Adult male Sprague-Dawley rats weighing approximately 200 g were used in all surgical procedures. Animals were anesthetized with xylazine (5 mg/kg) and ketamine (80 mg/kg) and surgery conducted with the animal's head secured firmly in a Kopf stereotaxic apparatus. For all surgical procedures, the incisor bar was 2.4 mm below the intra-aural plane.
Nucleus basalis lesions
Following placement of the animal in the stereotaxic apparatus, the skull was exposed, and a small burr hole was made with a dental drill. After removing the bone chip and incising the dura, a 30 gauge flat-tipped cannula was lowered into the brain. Ibotenic acid (10 #g//A dissolved in distilled water and adjusted to pH 7.4 with NaOH) was infused at a rate of 1 gl per 8 min 20 s. Each animal received a 0.5/A (31.6 nmol) injection to nbM. Some animals received an additional 0.5 gl injection of ibotenate into the anterior continuation of nucleus basalis at the level of the magnocellular preoptic nucleus. Coordinates for nbM were 1 mm posterior and 2.4 mm lateral to bregma and 6.6 mm ventral to the surface of the brain. Coordinates for magnocellular preoptic nucleus were 0.4 mm posterior and 2.4 mm lateral to bregma and 8.0 mm ventral to the surface of the brain.
37
A group of 8 rats received sham lesions by lowering the cannula into nbM and infusing 0.5 ~tl of 0.9% saline. Animals were allowed to survive 1 week, 1 month, or 2 months at which time they were decapitated and their brains rapidly removed. The brains were quickly frozen on dry ice and stored at -70 °C until use.
Cortical lesions
A small hole was drilled 5 mm lateral to bregma. The dura was incised and a 30 gauge flat-tipped cannula was lowered 2 mm into the brain. Ibotenic acid (1 jug/~l dissolved in distilled H20 and adjusted to pH 7.4 with NaOH) was infused at a rate of 1/A per 8 rain 20 s. Each animal received two 0.375 #l injections (2.37 nmol each), one 0.0 mm and the other 1.5 mm posterior to bregma. Following a I week survival period, animals were killed, their brains removed and frozen until use.
Entorhinal knife cuts
As with nbM-lesioned animals, rats were anesthetized, placed in a stereotaxic apparatus, an incision was made, and the fascia and muscle were retracted. A trench was then drilled in the skull 7 mm posterior to bregma extending from near the midline to the origin of the temporalis muscle. A razor blade approximately 2 mm wide was lowered 6 mm beneath the surface of the brain and moved from the midline to the lateral surface of the brain to cut the angular bundle and sever the fibers of the perforant pathway, as described by Gibbs et al.17 . In this study the contralateral hippocampus served as control. Animals survived for 1 week at which time they were decapitated, their brains removed, frozen quickly on dry ice and stored at -70 °C.
Dentate gyrus lesions
Surgical preparations were carried out as previously described. Following removal of the bone chip the dura was incised. A 30 gauge flat-tipped cannula was lowered into the brain, and colchicine, at a concentration of 5 ~g/#l (dissolved in distilled water and adjusted to pH 7.4), was infused at a rate of 1/A per 8 rain and 20 s. Each animal received two 0.5/A injections (12.5 nmol total) of colchicine to the dentate gyrus. A rostrai lesion was placed 3.4 mm posterior and 1.1 mm lateral to bregma and 3.8 mm ventral to the surface of the cortex. A caudal lesion was made 4.3 mm posterior and 2.0 mm lateral to bregma and 3.7 mm below the cortical surface. In this study, animals were allowed to survive for 1 week, then killed and their brains removed and frozen at -70 °C until assayed.
[~H]Glutamate incubation
On the day of the experiment, the frozen brains were mounted on cryostat chucks and equilibrated in the cryostat for one half hour prior to cutting. Sections (20 ~M) were then cut and thaw-mounted onto gelatin-coated slides. Slides were prewashed for 30 min in either ice-cold 50 mM Tris-HC1 buffer with 2.5 mM CaC12, pH 7. All sections were incubated in duplicate. Following incubation, the slides were rapidly rinsed 3 times with 3 ml of the appropriate ice-cold buffer, followed by one rinse with a solution of cold glutaraldehyde and acetone (1:19 v/v) and rapidly dried under a stream of heated air. The total rinse time in this assay did not exceed 10 s. 
[~H]TCP incubations
Autoradiography and data analysis
Sections were placed in an X-ray cassette and apposed to a piece of Ultrofilm 3H (LKB). A complete set of radioactive standards was co-exposed with each film. Following a 2 week exposure period at 4 °C, films were developed in D19 (Kodak), fixed and dried. Autoradiographic analysis was carried out using a previously described method 51. At least 15 densitometric readings were taken from each area of interest on each autoradiogram section. Anatomical correlations were determined using the atlases of Paxinos and Watson 53 and of Zilles TM. Scatchard curves were generated from saturation data using the program LIGAND 47. Quisqualate displacement curves were analyzed using the LIGAND program also. Readings from each series of lesioned animals were averaged and compared to the non-lesioned side using Student's t-test.
Acetylcholinesterase histochemistry and choline acetyltransferase assays
In 6 nbM-lesioned brains, the frontal poles were dissected and assayed for choline acetyltransferase activity (CHAT) according to the method of Fonnum 16 . Briefly, brain tissue homogenates were prepared (5%, w/v) and the enzyme liberated with 0.5% Triton X-100. Samples of the homogenate were then incubated in the presence of [14C]acetyl-coenzyme-A (acetyl-CoA) and choline bromide for 15 min at 37 °C. The reaction was stopped by rapidly chilling the incubation tubes and adding 5 ml cold phosphate buffer to each tube. The reaction mixtures were added to scintillation vials containing toluene, acetonitrile and sodium tetraphenyl boron and agitated gently to extract the [14C]acetylcholine reaction product into the organic phase. The amount of radioactivity in the organic layer was then counted in a Beckman LS8100 scintillation counter. Since water does not function as a scintillant, the [14C]acetyl-CoA that remained in the aqueous layer was not counted. The number of nmol of [14C]acetylcholine produced per mg protein per hour was then calculated.
In nbM-lesioned brains in which detailed saturation and displacement studies were carried out and in brains which had received 
RESULTS
Nucleus basalis lesions
Verification of nbM lesions at all time points was carried out by several tests. In animals in which frontal poles were dissected and assayed for CHAT, enzyme activity was reduced by 62% on the lesioned side ( Table  I ). The extensive reduction of ChAT activity in the frontal poles did not, however, ensure a loss of cholinergic innervation in the somatosensory cortex through which sections were taken for autoradiography. To determine the extent of cholinergic loss in this region, every tenth cryostat section through the region was stained for ACHE. A total of approximately 4 sections from each animal were stained in this manner.
Animals receiving single unilateral ibotenic acid injections to nbM displayed marked depletion of AChE positive reaction product in the ipsilateral neocortex (Fig.  1) . Loss of AChE staining included both motor and somatosensory cortices, but abruptly stopped at the anterior cingulate gyrus which has been shown to receive its cholinergic innervation from the vertical limb of the diagonal band an. Animals which received a second lesion to the magnoceilular preoptic nucleus showed additional depletion of AChE in the basolateral amygdaloid nucleus. In some animals caudal sections were obtained through nbM itself. In these animals loss of ACHEpositive neurons was observed in the lesioned nbM. In animals that had received sham lesions to the nbM there was no apparent decrease of AChE staining (not shown) in either cerebral cortex or nbM.
Scatchard analyses of L-[3H]glutamate binding in Tris-HC1 buffer in layers I and II of the somatosensory cortex of the non-lesioned side 1 week following surgery revealed a single binding site with a Bma x of 18 + 2.1 pmol/mg protein and K o of 320 + 60 nM (Fig. 2) . On the lesion side the Bma x was 18 + 2.0 pmol/mg protein and the Kd 310 + 40 nM. These values were not statistically different. Scatchard analyses of L-[3H]glutamate binding in layers V and VI, were also carried out (Fig. 3) . While the fiber projections of nbM project to all parts of the ipsilateral neocortex 2A2'31'44'55 contralateral projections may also exist 68. In an effort to preclude the possibility that no side to side changes were observed due to an underestimation of the bilaterality of nbM efferents, the total binding of [3H]glutamate was measured in the ipsilateral cortex of rats 1 week following lesions to the nbM and compared to total binding in the cortex of 8 rats which received sham lesions to nbM 1 week previously. In the control group, the Bma x (determined in Tris-HCl buffer) was 21 and VI was also evaluated 1 and 2 months following unilateral nbM lesions (Fig. 4) . At each time point, no significant changes were observed in Bma x between the lesioned and non-lesioned side in the respective layers. Table II) . Moreover, there was no significant difference in the absolute number of high-and low-affinity sites nor was there a difference in the affinity of the high (KH) and low (KL) affinity sites between the two sides (Table II) binding to either receptor in the cortex was observed when the lesioned side was compared to the non-lesioned side (Table III) . (Table III) .
There was also no change in affinity constants of [3H]glutamate over time (not shown). Quisqualic acid displacement of [3H]glutamate has been demonstrated to reveal high-and low-affinity sites
Cortical lesions
Entorhinal knife cuts
Eight animals received knife cuts to the angular bundle. Analysis of Cresyl violet stained cryostat sections taken at various dorsoventral levels revealed complete separation of the entorhinal cortex from the hippocampal formation in approximately the dorsal 3/4 of the hippocampal formation. Due to the nature of the surgery, the cut never extended through the most ventral and lateral portions of the entorhinal cortex and it is likely that some projections arising from pars lateralis remained intact. The striate and subicular cortices were also interrupted. In no case was there any evidence of damage to the hippocampus proper or the dentate gyrus. For receptor binding studies, 8 sequential sections were obtained from the dorsal hippocampal formation at a level where the subregions CA1, CA4 and the dentate gyrus could be clearly identified. The first 4 sections were assayed for NMDA receptors and the last 4 sections assayed for [3H]TCP binding. Densitometric readings of the dentate gyrus were taken from these sections in the region corresponding to the outer two thirds of the molecular layer.
Analysis of [3H]glutamate binding to NMDA receptors in the control dentate gyrus 1 week following knife cuts revealed that there were 4.38 + 0.21 pmol/mg protein glutamate bound. Ipsilateral to the lesion there was 3.99 + 0.26 pmol/mg protein glutamate bound. The difference between the lesioned and non-lesioned side was 9%, but (Table III) .
Dentate gyrus lesions
One week following application of colchicine, a near total loss of dentate gyrus granule cells was observed on visual inspection. Microscopic visualization under low power supported this finding and also showed marked inflammatory reaction in the region where dentate granule cells existed (Fig. 6) . Due to the loss of neurons, there was a narrowing of the space between the stratum oriens of CA1 and stratum oriens of CA4, as well as a reduction in the distance between CA1 and the dorsal thalamus.
Four sequential sections in each brain were assayed for NMDA receptors and 4 sequential sections assayed for [3H]TCP binding. As with animals with entorhinal knife cuts, densitometric readings of the dentate gyrus were taken from these sections in the outer two-thirds of the molecular layer. When the amount of [3H]glutamate binding to the NMDA receptor on the lesioned side was compared to the non-lesioned side of the dentate gyrus, an 84% reduction was observed (Table III) . Similarly, [3H]TCP binding was reduced approximately 92% in the colchicine-treated dentate gyrus compared to the untreated side (Table III) .
DISCUSSION
In this study the neuronal localization of both NMDAsensitive glutamate and dissociative anesthetic receptors was investigated. Previous studies have indicated that glutamate and compounds like PCP and ketamine regulate the release of cortical 34 and striatal acetylcholine 59. Furthermore both receptor types are known to be decreased in the brains of patients who have died with DAT 2° '21"39'54 . Most of the acetylcholine in the cortex is released from the terminals of nbM neurons 28. Since the nucleus basalis projects widely to the entire cortical mantle 2'12'31'44 and shows marked cell loss in DAT n'73 it was thought that at least some of the cortical NMDA and dissociative anesthetic receptors might be located on nbM terminals. Thus, the loss of NMDA receptors could be secondary to the degeneration of cholinergic terminals.
Following unilateral lesions to the nucleus basalis no changes were observed in either the total number of glutamate binding sites or their affinities when side to side comparisons were made at one week, two weeks or two months following surgery. Moreover, displacement studies showed that the proportion of high-and lowaffinity quisqualate binding sites remained constant following nbM lesions. The possibility that there was an inadequately placed lesion was ruled out by analyzing the efficacy of the lesion using AChE histochemistry. In addition, comparison of glutamate binding in nucleus basalis-lesioned rats to binding in sham-lesioned rats indicated no change in either the Bma x or Ko of glutamate binding. The values of [3H]TCP binding in the cortex, ipsilateral to the lesion were not significantly different from the contralateral cortex and were virtually identical to levels of binding seen in the cortex of normal rats 4°. These findings indicate that neither cortical NMDA nor [3H]TCP-labeled receptors exist on presynaptic terminals of cholinergic neurons originating in nbM.
An alternative hypothesis to the presynaptic localization of NMDA and TCP receptors is that they exist on neurons intrinsic to the cerebral cortex, lbotenic acid lesions made in the cortex resulted in a greater than 90% reduction of both NMDA (92%) and PCP (99%) binding sites. Ibotenic acid is a rigid heterocyclic analogue of glutamate known to make axon-sparing lesions 56. In this study, only regions in which AChE staining remained intact were analyzed, further strengthening the argument that the receptor loss was not due to degeneration of ascending cholinergic terminals. The near total reduction in NMDA and PCP receptors indicates that, at least in the cortex, the NMDA receptor complex exists on intrinsic neurons.
Unlike the cerebral cortex, physiological a and biochemical 6 studies in the hippocampal formation have suggested that NMDA receptors exist as presynaptic autoreceptors, regulating the release of glutamate from excitatory amino acid nerve endings. To test this latter possibility, binding to both NMDA and dissociative anesthetic receptors was studied in the outer two-thirds of stratum moleculare of the dentate gyrus following knife-cut lesions to the entorhinodentate pathway and following selective destruction of dentate granule cells using colchicine. The dentate gyrus contains a high density of both NMDA and PCP receptors 19'4°. The entorhinal cortex is the origin of a unidirectional projection system 6°'63 which provides the major glutamatergic innervation to the dentate gyrus 72. Lesions to this pathway have been shown to result in reduction of markers specific for glutamate terminals 48,61.
One week following knife cuts to this pathway a small (9%) but significant reduction of [3H]TCP binding was observed. An equally small reduction of NMDA receptors was measured, but this was not significant. This disparity may be due to the increased variance seen in the NMDA assay. These findings are consistent with those recently reported by Ulas et al. 66 who demonstrated a statistically not significant 'trend towards reduction in NMDA receptor binding levels' in the outer two-thirds of stratum moleculare 1-7 days following ipsilateral entorhinal cortex ablation. On the other hand, the small but significant reduction in TCP binding we observed contrasts with the absence of change in binding of [3H]MK-801 to the PCP site noted by Bekenstein et al. following unilateral entorhinal cortex lesions. This disparity may be due to several factors. Bekenstein et al. 1 removed afferent input to the dentate gyrus with electrolytic lesions of the entorhinal cortex which may have spared some cells of origin of the entorhinodentate pathway. Additionally, in analyzing their autoradiograms, they densitometrically averaged the area of the entire dorsal blade of the dentate gyrus (which includes the granule cell layer) while we measured a region limited to the outer two-thirds of the dorsal blade of the dentate gyrus. As the reduction we report in PCP receptor number is small, it is possible that this reduction might have been missed due to the dilutional effect of analyzing a larger, less homogenous region.
Destruction of the granule cells, on the other hand, resulted in an almost 90% reduction of both receptors. Similar but less marked (50-60%) reduction in [3H]MK-801 binding was reported by Bekenstein et al. following colchicine administration to the dentate gyrus 1. Their study, however, used smaller amounts of colchicine per lesion which likely resulted in less complete destruction of the granule cell and subsequently more residual binding. Taken together, it appears that nearly all of the NMDA and TCP receptors in the dentate gyrus exist on granule cell dendrites and that no more than 10% exist presynaptically as autoreceptors on entorhinodentate glutamate terminals. A predominantly postsynaptic localization of NMDA receptors has also been shown to occur in the CA1 region of the rat hippocampal formation 9. In a previous study by Werling and Nadler, significant reductions (about 45%) of binding to glutamate receptors in the dentate gyrus were not observed until almost 3 weeks following destruction of the entorhinal cortex 71. Werling and Nadler, however, used fresh membrane preparations for binding assays. Since there is a large population of non-NMDA glutamate binding sites detectable in fresh but not frozen tissue 14, it is likely that the receptors they described were non-NMDA. Nevertheless, since it had been shown that dendritic spines degenerated in the dentate gyrus 1 week following lesions to entorhinal cortex 4'52, these authors concluded that the population of glutamate receptors they analyzed existed postsynaptically. This seems unlikely however, since at 3 weeks, reacquisition of spines to control levels may have been almost complete 4,52.
It has been argued that NMDA receptors exist on astrocytes and that alterations in NMDA binding following lesions may parallel quantitative changes in glial elements. In a recent study by Greenamyre and Young 22, quinolinic acid lesions in the rat striatum resulted in a 92% reduction of NMDA binding. Quinoiinic acid is an endogenous metabolite of tryptophan that selectively destroys neurons 57. In the rat striatum, cell loss results in a marked inflammatory response with gliosis that is evident at 7 days after quinolinate application and persists up to one year 3. If the NMDA receptor complex exists on glial cells, then one would not have expected such a marked reduction in NMDA binding during a period of glial proliferation.
In this study, we have shown that the NMDA receptor complex exists predominantly on either the cell bodies or dendrites of neurons intrinsic to the cortex and hippocampal formation. In Alzheimer's disease, there is extensive loss of pyramidal neurons in both of these regions 49'64. Studies using the Golgi technique have indicated that these neurons project apical and basilar dendrites to precisely those layers in which NMDA receptor loss is greatest 36'37. In Alzheimer's disease, retraction of dendritic spines 38"43 and cell loss 49"64 in these layers may account for the observed reductions of NMDA receptors.
